ArticleJournal of minimally invasive surgery2026
Operative workflow characterization of the Hugo robotic-assisted surgery and da Vinci Multiport systems in left-sided colorectal surgery: a single-institution pilot analysis.
Article in Journal of minimally invasive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The modular four-cart design of the Hugo robotic-assisted surgery (RAS) system raises a practical concern: does it impose a greater operative workflow burden than established platforms? We characterized operative workflow across the Hugo RAS and da Vinci Multiport systems, incorporating a concurrent mature-adoption Multiport cohort as an institutional maturity reference. Methods: This retrospective study analyzed 15 consecutive qualifying cases per cohort: Hugo RAS, initial da Vinci Multiport (de novo adoption), and recent da Vinci Multiport (mature adoption, concurrent with Hugo RAS). Primary endpoints were workflow time intervals across five phases derived from prospectively recorded timestamps. Secondary endpoints included 30-day complications, TME completeness, lymph node yield, and resection margin status. Results: Hugo RAS access phase (27 minutes; IQR, 20-55 minutes) was equivalent to both the initial (p > 0.999) and recent Multiport cohorts (p = 0.693). Nonsurgical time was equivalent between Hugo RAS and recent Multiport cohorts (45 vs. 40 minutes; p = 0.461), operated by the same team at identical institutional maturity. Workflow differences between Hugo RAS and initial Multiport were mirrored by equivalent differences between initial and recent Multiport cohorts-implicating institutional maturity rather than platform effects. TME completeness was 100% in all evaluable cases, and lymph node yield was equivalent across all cohorts (all pairwise p > 0.999). Conclusion: The Hugo RAS four-cart architecture did not impose a greater workflow burden than the da Vinci Multiport system under equivalent institutional conditions. Remaining differences reflected case-mix heterogeneity and asymmetric adoption maturity, supporting continued multi-platform robotic colorectal program development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.